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Abstract
Background: The orifice area of mitral bioprostheses provides important information regarding their hemodynamic 
performance. It is usually calculated by transthoracic echocardiography (TTE), however, accurate and reproducible 
determination may be challenging. Cardiovascular magnetic resonance (CMR) has been proven as an accurate 
alternative for assessing aortic bioprostheses. However, whether CMR can be similarly applied for bioprostheses in the 
mitral position, particularly in the presence of frequently coincident arrhythmias, is unclear. The aim of the study is to 
test the feasibility of CMR to evaluate the orifice area of mitral bioprostheses.
Methods: CMR planimetry was performed in 18 consecutive patients with mitral bioprostheses (n = 13 Hancock®, n = 4 
Labcore®, n = 1 Perimount®; mean time since implantation 4.5 ± 3.9 years) in an imaging plane perpendicular to the 
transprosthetic flow using steady-state free-precession cine imaging under breath-hold conditions on a 1.5T MR 
system. CMR results were compared with pressure half-time derived orifice areas obtained by TTE.
Results: Six subjects were in sinus rhythm, 11 in atrial fibrillation, and 1 exhibited frequent ventricular extrasystoles. 
CMR image quality was rated as good in 10, moderate in 6, and significantly impaired in 2 subjects. In one prosthetic 
type (Perimount®), strong stent artifacts occurred. Orifice areas by CMR (mean 2.1 ± 0.3 cm2) and TTE (mean 2.1 ± 0.3 
cm2) correlated significantly (r = 0.94; p < 0.001). Bland-Altman analysis showed a 95% confidence interval from -0.16 to 
0.28 cm2 (mean difference 0.06 ± 0.11 cm2; range -0.1 to 0.3 cm2). Intra- and inter-observer variabilities of CMR 
planimetry were 4.5 ± 2.9% and 7.9 ± 5.2%.
Conclusions: The assessment of mitral bioprostheses using CMR is feasible even in those with arrhythmias, providing 
orifice areas with close agreement to echocardiography and low observer dependency. Larger samples with a greater 
variety of prosthetic types and more cases of prosthetic dysfunction are required to confirm these preliminary results.
Background
The hemodynamic evaluation of heart valve bioprosthe-
ses is based on a comprehensive assessment of transpros-
thetic pressure gradients and orifice area, preferably by
using transthoracic echocardiography (TTE) [1]. How-
ever, TTE is frequently limited due to restricted acoustic
windows following cardiac surgery and due to methodical
concerns [2]. In particular, the assessment of the pros-
thetic orifice area, which is the main parameter used to
differentiate between a normal functioning prosthesis,
prosthetic stenosis and patient-prosthesis mismatch,
often remains a challenge.
Recently, cardiovascular magnetic resonance (CMR)
has been identified as an accurate non-invasive tool for
the assessment of the orifice area of bioprostheses
implanted in the aortic position. The orifice areas
obtained by CMR planimetry agreed well with those
obtained by TTE and transesophageal echocardiography,
and artifacts caused by flow turbulences and prosthetic
material were rare [3].
Based on these experiences with aortic bioprostheses,
and on the established application of CMR to assess the
severity of native mitral stenosis [4,5], it would be desir-
able to apply this method to bioprostheses implanted in
the mitral position. However, whether CMR can be
applied to mitral bioprostheses is unclear, particularly
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Page 2 of 8due to the frequent coincidence of arrhythmias. There-
fore, the aim of this study was to determine the feasibility
of CMR to quantify the orifice area of mitral bioprosthe-
ses and compare the results to TTE.
Methods
Patient population
The inclusion criterion for entry into the study was the
presence of a biological mitral prosthesis; exclusion crite-
ria were general contraindications for CMR [6]. Screen-
ing the database of all patients who underwent
echocardiography at our hospital between 2007 and 2009,
we identified 138 patients who had undergone mitral
valve replacement. Eighteen patients were eligible for the
study. Their characteristics and distribution of valve
types are depicted in Table 1. One hundred and twenty
patients did not meet the inclusion criteria, since (possi-
ble nomination of ≥1 reason in each subject) the mitral
prosthesis was a mechanical device (n = 74), due to the
presence of a pacemaker (n = 29) or internal converter
defibrillator (n = 8), because they refused to participate (n
= 13) or had claustrophobia (n = 3). The study was car-
ried out in compliance with the Declaration of Helsinki,
the institutional ethics committee approved the study
(EA3/015/07), and all patients gave written informed
consent.
Transthoracic echocardiography
TTE was performed on state-of-the-art ultrasound sys-
tems (General Electric Healthcare, Vivid 7, Waukesha,
USA; Philips Medical Systems, IE33, Andover, USA) in
accordance with international guidelines [1,7]. In the
presence of arrhythmia, each measurement was repeated
at least five times and a mean result was calculated. Peak
and mean transprosthetic pressure gradients were
obtained using the modified Bernoulli equation. Pros-
thetic orifice area was calculated based on the pressure
half time [8].
Cardiovascular magnetic resonance
All patients underwent CMR in a clinical 1.5-Tesla MR
scanner (Magnetom Avanto, Siemens Healthcare, Erlan-
gen, Germany). For prosthetic orifice visualization,
steady-state free-precession (SSFP) cine images were
acquired during expiratory breath-holds and with retro-
spective electrocardiographic gating. Imaging parameters
were: slice thickness 5 mm; no gap; repetition time 2.9
ms; echo time 1.2 ms; flip angle 80°; field of view 340 to
380 mm2; matrix 256 × 146; bandwidth 930 Hz/px; 30
phases per R-R-interval. In a subgroup of 13 patients,
prosthetic orifice was additionally depicted using fast
gradient echo (FGRE) cine loops. Imaging parameters
were: slice thickness 5 mm, no gap, repetition time 6.5
ms, echo time 3.1 ms; flip angle 15°; field of view 340 to
380 mm2, matrix 192 × 125, bandwidth 260 Hz/px, 25
phases per R-R interval.
Positioning of the cine loops for orifice planimetry was
performed in a stepwise fashion to ensure accurate posi-
tioning of the imaging plane perpendicular to the trans-
prosthetic jet (Figure 1): Based on the four- or three-
chamber-view, two subsequent planes were positioned
centrally through the transprosthetic jet. Then, a stack of
about six slices perpendicular to the jet was planned. Pla-
nimetry of the diastolic orifice area was performed in a
single frame based on cross-references using the software
CMR42 (CIRCLE Cardiovascular Imaging, Calgary,
Alberta, Canada).
Images were rated regarding overall image quality on a
scale from 0 to 3 (0 poor, non-diagnostic; 1 impaired
image quality that may lead to misdiagnosis; 2 moderate;
3 good). To test intra-observer variability of CMR pla-
nimetry, one investigator (FvK) analyzed all examinations
twice with a latency of at least three months. To test
inter-observer variability, two independent observers
Table 1: Patient characteristics and distribution of prosthetic valve 
types
Number of patients completing TTE and 
CMR
18
Gender (male/female) 7/11
Mean age (range) at study enrollment [years] 73.7 ± 5.7 (64.0 - 82.8)
Mean time (range) since mitral valve 
replacement [years]
4.9 ± 3.5 (0.6 - 10.9)
Mean left ventricular ejection fraction 
(range) [%]
44.6 ± 15.3 (10 - 64)
Mean left atrial area [cm2] 31.1 ± 11.1 (18-58)
Native mitral valvular lesion
Mitral regurgitation 11
Mitral stenosis 4
Combined mitral lesion 3
Heart rhythm
Sinus rhythm 6
Atrial fibrillation 11
Frequent ventricular extrasystoles 1
Prosthetic types
Medtronic Hancock® 13
Labcore® 4
Carpentier Edwards Perimount® 1
Prosthetic sizes
27 4
29 7
31 6
33 1
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tions, performed planimetry.
Examination of ventricular function was performed by
acquisition of SSFP cine images in standard four- and
two-chamber views, and where wall motion abnormali-
ties were present, in a stack of short axes covering the
whole left ventricle (imaging parameters as described
elsewhere [3]).
Statistical Analysis
Results are presented as mean ± standard deviation. Cor-
relations between orifice areas obtained by TTE and
CMR were analyzed using the Spearman rank order cor-
relation test and are displayed as scattergrams with
regression line. Bland-Altman analysis was used to evalu-
ate the agreement between orifice area measurements
according to the various methods, and to determine
observer-related variability. Statistical significance was
implied where p < 0.05. Statistical analyses were per-
formed using Prism 5.0 (Graphpad Software, La Jolla,
CA, USA).
Results
Echocardiographic assessment of mitral bioprostheses
Peak and mean transprosthetic pressure gradients were
11.5 ± 4.9 mmHg (range 6-22 mmHg) and 4.6 ± 2.5
mmHg (range 2-11 mmHg). Mean pressure half time was
110.8 ± 26.9 ms (range 85-192 ms). Mean prosthetic ori-
fice area was 2.1 ± 0.3 cm2 (range 1.5-2.6 cm2). Prosthetic
regurgitation was present in 16 subjects (15 mild, 1
severe). Aortic and tricuspid regurgitation were present
in 16 (13 mild, 3 moderate) and 18 (10 mild, 8 moderate)
subjects. There was no patient without any left-sided val-
vular regurgitation. Five subjects had concomitant bio-
logical aortic valve replacement.
Feasibility of CMR to image the mitral bioprosthesis
The image quality was rated as "good" in 10 (Figure 2,
Additional file 1), "moderate" in 6 and "impaired that may
lead to misdiagnosis" in 2 subjects. The reason for the sig-
nificantly impaired image quality in 2 patients were con-
siderable artifacts caused by the prosthetic stent in one
subject (Figure 2, Additional file 2), and artifacts caused
Figure 2 Mitral bioprostheses imaged by CMR. A) and B) Hancock® 
#29, implanted 1998, imaged during sinus rhythm. C) and D) Labcore® 
#29, implanted 2005, imaged during atrial fibrillation. E) and F) Peri-
mount® #31, implanted 2001, imaged during atrial fibrillation, with 
strong artifacts caused by the stent.
Figure 1 Slice positioning for prosthetic orifice planimetry. A) and 
B) 3- and 4-chamber-view showing the mitral bioprosthesis. Planning 
the next slice in the 4-chamber view along the transprosthetic jet 
(white line). C) Again planning the next plane centrally through the 
transprosthetic jet. D) Positioning a stack of slices perpendicular to the 
jet covering the prosthesis during cardiac motion. E) and F) Cross sec-
tion of the mitral bioprosthesis in systole and diastole. G) Manual con-
touring of the largest diastolic orifice area.
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breath holding in the other. The image quality rating dif-
fered significantly between evaluations in the presence
and absence of arrhythmias (2.2 vs. 3.0; p = 0.013). All
subjects in sinus rhythm had "good" image quality, and all
subjects with "moderate" or "impaired" image quality had
arrhythmias. On the other hand, even 4 subjects with
atrial fibrillation achieved "good" image quality. In five
subjects, an impaired opening movement of at least one
valvular cusp was detected by CMR (Additional file 3).
Accuracy of quantification of the mitral prosthetic orifice 
area by CMR
Mean prosthetic orifice area obtained by CMR was 2.1 ±
0.3 cm2 (n = 18; range 1.5 to 2.7 cm2). Correlation analysis
with TTE was significant (r = 0.94; p < 0.001) (Figure 3).
Bland-Altman analysis revealed a 95% confidence interval
ranging from -0.16 to 0.28 cm2 when comparing TTE-
and CMR-derived orifice areas (mean difference 0.06 ±
0.11 cm2, range -0.1 to 0.3 cm2) (Figure 3).
Bland-Altman analysis of TTE- and CMR-derived ori-
fice areas in dependence of the heart rhythm revealed a
95% confidence interval from -0.27 to 0.20 cm2 (mean dif-
ference -0.03 ± 0.12 cm2, range -0.2 to 0.1 cm2) in subjects
with sinus rhythm (n = 6), and from -0.28 to 0.13 cm2
(mean difference -0.08 ± 0.11 cm2, range -0.3 to 0.1 cm2)
in subjects with arrhythmias (n = 12). Bland-Altman
analysis of TTE- and CMR-derived orifice areas referring
to image quality showed a 95% confidence interval from -
0.20 cm2 to 0.18 cm2 (mean difference -0.01 ± 0.10 cm2,
range -0.2 to 0.1 cm2) in "good" image quality (n = 10),
and from -0.30 to 0.05 cm2 (mean difference -0.13 ± 0.09
cm2; range -0.3 to 0.0 cm2) in "moderate" and "impaired"
image quality (n = 8).
Agreement between both methods was similar for ori-
fice areas smaller than the median 2.1 cm2 (n = 8; 95%
confidence interval -0.17 to 0.27 cm2; mean difference
0.05 ± 0.11 cm2) and ≥2.1 cm2 (n = 10; 95% confidence
interval -0.17 to 0.31 cm2; mean difference 0.07 ± 0.12
cm2).
Regarding the application of FGRE for planimetry,
Bland-Altman analysis revealed a 95% confidence interval
ranging from -0.37 to 0.31 cm2 when comparing SSFP and
FGRE (mean difference -0.03 ± 0.17 cm2; range -0.3 to 0.3
cm2) and from -0.29 to 0.35 cm2 when comparing FGRE
and TTE (mean difference 0.03 ± 0.16 cm2; range -0.2 to
0.4 cm2). Figure 4 shows a mitral bioprosthesis imaged by
FGRE and SSFP (Additional file 4).
Intra- and inter-observer variability of CMR planimetry
Repeated measurements of prosthetic orifice area by
CMR-planimetry by one investigator resulted in an intra-
observer variability of 4.5 ± 2.9% (range 0 to 9.5%). Bland-
Altman analysis revealed a mean difference of 0.03 ± 0.11
cm2 (range -0.2 to 0.2 cm2; 95% confidence interval -0.19
to 0.25 cm2). Assessment by two blinded observers
revealed an inter-observer variability of 7.9 ± 5.2% (0.0 to
21.1%). Bland-Altman analysis revealed a mean difference
of -0.08 ± 0.19 cm2 (range -0.4 to 0.2 cm2; 95% confidence
interval -0.30 to 0.46 cm2).
Discussion
Planimetry is the most direct, and thus should be the
most stable approach to determine a valvular orifice area.
It is not derived from other hemodynamic and geometric
calculations and hence is widely independent from hemo-
dynamic conditions. For mitral valves, planimetry
showed the best correlation with anatomical mitral valve
area as assessed on explanted valves [9] and is therefore
Figure 3 Comparison of CMR and TTE. Scattergram (left) and Bland-Altman plot (right) comparing the prosthetic orifice areas obtained by CMR and 
TTE. (Middle dotted line indicates the mean difference; outer dotted lines indicate the limits of 2 standard deviations of the difference).
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area [10]. Based on the successful application of CMR
planimetry in aortic bioprostheses, we hypothesized that
CMR planimetry of mitral bioprostheses would also pro-
vide accurate orifice areas, as long as the image quality
allows for a clear-cut delineation of the prosthetic cusp
borders.
Feasibility of CMR to image mitral bioprostheses
We have demonstrated the feasibility of CMR to image
mitral bioprostheses, even in the presence of arrhyth-
mias. Indeed, only 6 subjects presented in sinus rhythm,
while 1 had frequent ventricular extrasystoles and 11
were experiencing atrial fibrillation. This incidence of
arrhythmia is typical for patients previously suffering
from mitral regurgitation or stenosis and having atrial
dilatation [11]. As SSFP cine movies collect data over sev-
eral cardiac cycles, the image quality negatively correlates
with the extent of arrhythmia and with increasing heart
rate. Even in the present sample, differences in image
quality were observed between patients in sinus rhythm
and those with arrhythmia. Nevertheless, none of the
examinations hat to be excluded due to non-diagnostic
image quality. But, optimal heart rate control is recom-
mended preceding the assessment of a mitral bioprosthe-
sis by CMR.
A strong stent artifact appeared in one subject with a
Perimount® prosthesis, whereas this phenomenon did not
occur in the remaining subjects, who received other types
of devices. This underlines that some prostheses are less
suitable for CMR assessment and that the type of the
valve makes an important difference concerning image
quality. The differences probably depend on the shape
and quantity of metal within the stent, and on its compo-
sition, which is a cobalt-chromium spring alloy in the
Perimount®. Further trials including a greater variety of
prosthetic types are warranted.
Artifacts caused by turbulent flow did not constitute a
significant challenge in mitral prostheses, which can be
attributed to the low transmitral blood flow velocity.
Therefore, SSFP is the sequence of choice despite its gen-
eral susceptibility for turbulent flow [12,13]. In rare cases
with flow artifacts, less flow sensitive FGRE [13] may be
applied. However, mitral prosthetic orifice areas obtained
by FGRE showed less agreement with TTE than those
determined by SSFP, which is in accordance with the use
of FGRE to evaluate aortic stenosis [14].
Accuracy of CMR to quantify the orifice area of mitral 
bioprostheses
Direct comparison of the orifice areas obtained by CMR
planimetry with a gold standard would be desirable to
confirm our hypothesis that CMR of mitral bioprostheses
provides accurate prosthetic orifice areas. However, a
true gold standard does not exist. Even when evaluating
native mitral stenosis it is recommended that calculated
mitral valve area by any one method should not be used
as the single measure of severity of stenosis [15]. Orifice
areas provided by the manufacturers are not a suitable
gold standard, as they mostly comprise the geometric ori-
fice area in-vitro, which is different from the orifice area
effectively used in-vivo [16]. Planimetry using echocar-
diography is complicated by difficulties in identifying the
correct cross-section [17,18]. Three-dimensional imaging
may improve echocardiography [19,20], but has not yet
entered routine clinical practice. The accuracy and repro-
ducibility of the continuity equation are hampered by the
number of contributing measurements, which is even
more problematic in arrhythmias [18]. Furthermore, this
algorithm is inappropriate in those with aortic or mitral
regurgitation, as in our study subjects. The validity of
pressure half time derived orifice areas, as traditionally
applied in native mitral stenosis [8], is unclear in pros-
thetic valves, because of the dependence on left ventricu-
lar and left atrial compliance, on left atrial pressure and
heart rate [1,21-23]. Nevertheless, in the absence of a bet-
ter standard, and bearing these limitations in mind, we
selected this parameter as the most appropriate for our
study.
CMR planimetry of mitral bioprosthetic orifice area
was significantly correlated with data obtained by TTE.
The agreement between both methods was similar to the
successful application of CMR to assess native mitral
valve stenosis by Djavidani et al. (r = 0.98; mean differ-
ence 0.03 ± 0.09 cm2) [24] and even superior compared to
Figure 4 Comparison of SSFP and FGRE. Hancock® #31, implanted 
2008, imaged during sinus rhythm by SSFP (A and B) and FGRE (C and 
D).
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0.13 ± 0.24 cm2) [4]. Compared to the application of com-
puted tomography to assess native mitral valves in com-
parison to TTE-planimetry (r = 0.88; mean difference
0.20 ± 0.17 cm2) [25], the present results in mitral bio-
prostheses showed even closer agreement. In comparison
to our results of CMR and TTE to assess aortic biopros-
theses (r = 0.82; mean difference -0.02 ± 0.24 cm2) [3], the
limits of agreement of CMR and TTE in mitral prosthetic
assessment were smaller.
The present results demonstrated similar agreement
between CMR- and TTE- derived orifice areas both in
the presence or absence of arrhythmias. There was a ten-
dency towards underestimation of orifice areas using
CMR compared to TTE in examinations rated with
"moderate" and "impaired" image quality, which may be
explained by less accurate delineation of the border
between blood and prosthetic cusps. However, the sam-
ple size is too small to draw firm conclusions regarding
the influence of arrhythmias and image quality on pros-
thetic orifice assessment; thus, larger series are required.
CMR and TTE showed agreement that was indepen-
dent of prosthetic orifice area. However, the study sample
only contained 3 patients with an orifice area ≤1.7 cm2
and just 1 patient with an orifice area ≤1.5 cm2. Prosthetic
dysfunction may be associated with increased turbulent
flow causing significant flow artifacts, which may influ-
ence image interpretation. Therefore, larger clinical trials
are required to extend the use of CMR to the assessment
of dysfunctional mitral prostheses.
The inter- and intra-observer variabilities of CMR pla-
nimetry were low and within the range of accepted
echocardiographic results that report 5% to 8% variability
for experienced observers examining native aortic valves
[26]. Observer dependency was also comparable to data
obtained using CMR in aortic bioprostheses with an
intra- and interobserver variablity of 6.7% and 11.5%,
respectively [3].
Clinical impact of CMR to quantify the orifice area of mitral 
bioprostheses
TTE will remain the first choice for the assessment of
mitral bioprostheses due to its ready availability, even
bedside in the intensive care, cost effectiveness, non-
invasiveness and proven accuracy. Bioprosthetic mitral
valves constitute a very small number of patients under-
going mitral valve surgery, and of those an even smaller
percentage will have unfavorable acoustic windows mak-
ing Doppler interrogation unreliable. Nevertheless the
present results demonstrated that for selected subjects,
e.g. in case of insufficient acoustic windows, discordant
echocardiographic results or within clinical research
regarding patient-prosthesis mismatch [27], CMR pla-
nimetry poses a reliable non-invasive method to quantify
the prosthetic orifice area.
Conclusions
We demonstrated the feasibility of CMR to image mitral
bioprostheses and to accurately assess the orifice area
with close agreement to echocardiography and low
observer dependency. Even though image quality
decreased with the presence of arrhythmias and seemed
to depend on the prosthetic type, all CMR examinations
provided diagnostic image quality. Further clinical studies
including patients with prosthetic dysfunction and a
greater variety of prosthetic types are necessary to fully
elucidate the applicability of these findings to a wider
population.
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